Abiopharma

🔍 Guyer William (Executive)

Company: CORCEPT THERAPEUTICS INC (CORT)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Common Stock at $21.65 per share (Direct)
  Date: 2026-01-06 | Code: M | equity_swap_involved: false | shares_owned_after: 21,235.00 | transaction_form_type: 4
• Sold 20,000 shares of Common Stock at $35.1828 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 1,235.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 20,000 shares of Stock option (right to buy) at $21.65 per share (Derivative)
  Date: 2026-01-06 | Code: M | Expires: 2031-09-01 | equity_swap_involved: false | shares_owned_after: 250,000.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
• F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $34.96 to $35.50 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F3: Fully exercisable.
• REMARKS: The power of attorney under which this form was signed is on file with the Commission.